C. Wasylyk

发表

Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity

B. Wasylyk, C. Wasylyk, S. Schlumberger, 2002, Molecular and Cellular Biology.

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC)

L. Bracco, B. Wasylyk, J. Abecassis, 2003, British Journal of Cancer.

Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy

H. Klocker, J. Schalken, G. Schaefer, 2010, International journal of cancer.

The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation

B. Wasylyk, D. Leprince, B. Wasylyk, 1990, Nature.

Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display

L. Bracco, A. Carles, D. Dembélé, 2006, Oncogene.

Short and long range activation by the SV40 enhancer.

P. Chambon, B. Wasylyk, C. Wasylyk, 1984, Nucleic acids research.

The immunoglobulin heavy chain enhancer is stimulated by the adenovirus type 2 E1A products in mouse fibroblasts.

P. Chambon, E. Borrelli, B. Wasylyk, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer

B. Wasylyk, J. Imler, C. Lemaire, 1987, Molecular and cellular biology.

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature.

B. Wasylyk, J. Abecassis, M. Suarez-Carmona, 2015, Oral oncology.

A novel modulator domain of Ets transcription factors.

B. Wasylyk, C. Wasylyk, J. Kerckaert, 1992, Genes & development.

The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage

B. Wasylyk, A. Pintzas, C. Wasylyk, 2010, Molecular and Cellular Neuroscience.

Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression

B. Wasylyk, A. Gutierrez-Hartmann, A. Bradford, 1997, Molecular and cellular biology.

Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain

B. Wasylyk, A. Gutierrez-Hartmann, A. Bradford, 1995, Molecular and cellular biology.

Expression of raf oncogenes activates the PEA1 transcription factor motif

B. Wasylyk, U. Rapp, G. Heidecker, 1989, Molecular and cellular biology.

A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum

B. Wasylyk, J. Imler, C. Wasylyk, 1988, Nature.

The Oncogenic MicroRNA Hsa-miR-155-5p Targets the Transcription Factor ELK3 and Links It to the Hypoxia Response

B. Wasylyk, T. Ye, C. Wasylyk, 2014, PloS one.

PEA1 transcription factor motif. Expression of raf oncogenes activates the

B. Wasylyk, U. Rapp, G. Heidecker, 2013 .

v-jun is a transcriptional activator, but not in all cell-lines.

B. Wasylyk, J. Imler, C. Wasylyk, 1988, Nucleic acids research.

Oncogene v-jun modulates DNA replication.

B. Wasylyk, C. Wasylyk, J. Schneikert, 1990, Oncogene.

PEA3 is a nuclear target for transcription activation by non‐nuclear oncogenes.

B. Wasylyk, C. Wasylyk, A. Gutman, 1989, The EMBO journal.

Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules.

B. Wasylyk, L. Debussche, Hong Zheng, 2008, Cancer research.

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice

J. Schalken, B. Wasylyk, G. van der Pluijm, 2016, PloS one.

ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines

A. Reyniès, B. Wasylyk, J. Abecassis, 2010, British Journal of Cancer.

Oncogenic conversion of Ets affects redox regulation in-vivo and in-vitro.

B. Wasylyk, C. Wasylyk, 1993, Nucleic acids research.

Oncogenic conversion alters the transcriptional properties of ets.

B. Wasylyk, C. Wasylyk, 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins.

B. Wasylyk, R. Nicholson, C. Wasylyk, 1991, The EMBO journal.

p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53

B. Wasylyk, J. Abecassis, L. Debussche, 1999, Oncogene.

The SV40 72 bp repeat preferentially potentiates transcription starting from proximal natural or substitute promoter elements

P. Chambon, B. Wasylyk, C. Wasylyk, 1983, Cell.

The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer

B. Wasylyk, J. Imler, C. Wasylyk, 1987, Cell.

Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter.

M. Oren, B. Wasylyk, G. Fiucci, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net

B. Wasylyk, C. Wasylyk, Paola Criqui-Filipe, 2005, Oncogene.

The transcription factor Net regulates the angiogenic switch.

J. Schalken, B. Wasylyk, J. Abecassis, 2003, Genes & development.

B-lymphocyte targeting of gene expression in transgenic mice with the immunoglobulin heavy-chain enhancer.

B. Wasylyk, M. Lemeur, P. Gerlinger, 1986, Nucleic acids research.

250 in Cell Cycle Mutant tsBN462 Cells II Loop Resulting from Inactivation of TAF Defect in the p53-Mdm2 Autoregulatory

B. Wasylyk, C. Wasylyk, 2014 .

CTIP2 Expression in Human Head and Neck Squamous Cell Carcinoma Is Linked to Poorly Differentiated Tumor Status

B. Wasylyk, J. Abecassis, R. Millon, 2009, PloS one.

Transforming but not immortalizing oncogenes activate the transcription factor PEA1.

B. Wasylyk, J. Imler, C. Wasylyk, 1988, The EMBO journal.

Tubulin Tyrosine Ligase Like 12, a TTLL Family Member with SET- and TTL-Like Domains and Roles in Histone and Tubulin Modifications and Mitosis

J. D. De Mey, A. Carles, J. Schalken, 2012, PloS one.

Transcription from the SV40 early‐early and late‐early overlapping promoters in the absence of DNA replication.

M. Wintzerith, P. Chambon, B. Wasylyk, 1983, The EMBO journal.

Preferential Response of Basal-Like Head and Neck Squamous Cell Carcinoma Cell Lines to EGFR-Targeted Therapy Depending on EREG-Driven Oncogenic Addiction

B. Wasylyk, N. Etienne-Selloum, A. de Reyniès, 2019, Cancers.

Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2

B. Wasylyk, A. Gutierrez-Hartmann, A. Bradford, 1997, Oncogene.

Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter

B. Wasylyk, C. Wasylyk, A. Gutman, 1991, Molecular and cellular biology.

The immunoglobulin heavy‐chain B‐lymphocyte enhancer efficiently stimulates transcription in non‐lymphoid cells.

B. Wasylyk, C. Wasylyk, 1986, The EMBO journal.

Defect in the p53-Mdm2 Autoregulatory Loop Resulting from Inactivation of TAFII250 in Cell Cycle Mutant tsBN462 Cells

B. Wasylyk, C. Wasylyk, 2000, Molecular and Cellular Biology.

Reversion of Ras transformed cells by Ets transdominant mutants.

B. Wasylyk, S. Maira, C. Wasylyk, 1994, Oncogene.

Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays

D. Rickman, A. Reyniès, B. Wasylyk, 2008, Oncogene.

Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.

B. Wasylyk, J. Imler, C. Wasylyk, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Elk3 Deficiency Causes Transient Impairment in Post-Natal Retinal Vascular Development and Formation of Tortuous Arteries in Adult Murine Retinae

S. Beck, Marina Garcia Garrido, V. Sothilingam, 2014, PloS one.

TTLL12 has a potential oncogenic activity, suppression of ligation of nitrotyrosine to the C-terminus of detyrosinated α-tubulin, that can be overcome by molecules identified by screening a compound library

G. Verhaegh, C. Wasylyk, J. Brants, 2024, PloS one.

Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy

H. Klocker, J. Schalken, G. Schaefer, 2010, International journal of cancer.